Circulating immune checkpoints predict heart failure outcomes

Circulating immune checkpoints predict heart failure outcomes

Abstract Aims There are limited data examining the role of immune checkpoint (IC) ligands in the pathophysiology of heart failure (HF). Therefore, we explore this in three HF animal models and in three different human cohorts (healthy, stable, and worsening HF). Methods and results Transcriptomic an...

書目詳細資料
Main Authors:	Elles M. Screever, Laura I.E. Yousif, Javid J. Moslehi, Joe‐Elie Salem, Adriaan A. Voors, Herman H.W. Silljé, Rudolf A. deBoer, Wouter C. Meijers
格式:	Article
語言:	English
出版:	Wiley 2023-08-01
叢編:	ESC Heart Failure
主題:	Immune checkpoints PD‐L1 PD‐L2 Galectin‐9 Heart failure
在線閱讀:	https://doi.org/10.1002/ehf2.14304

相似書籍

Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study
由: Douglas B. Johnson, et al.
出版: (2019-05-01)

Checkpoint Inhibition in Myeloma: Opportunities and Challenges
由: Federica Costa, et al.
出版: (2018-09-01)

The role of immune checkpoints in cardiovascular disease
由: Laura I. Yousif, et al.
出版: (2022-10-01)

Enhancing cancer care with improved checkpoint inhibitors
由: Vickram A S, et al.
出版: (2024-10-01)

Checkmate with checkpoint inhibitors: New paradigm in immunotherapy
由: Ruby Dhar, et al.
出版: (2023-04-01)

Characterization of PD-1/PD-L1 Immune Checkpoint Expression in Osteosarcoma
由: Kazuhiko Hashimoto, et al.
出版: (2020-07-01)

Immune Checkpoint in Glioblastoma: Promising and Challenging
由: Jing Huang, et al.
出版: (2017-05-01)

Phytochemicals in Cancer Immune Checkpoint Inhibitor Therapy
由: Juwon Lee, et al.
出版: (2021-07-01)

Overview of the Cardiotoxicity Induced by PD-1/PD-L1 Immune Checkpoint Inhibitor in Critical Care
由: Ruiting Li, et al.
出版: (2021-06-01)

On Demand Biosensors for Early Diagnosis of Cancer and Immune Checkpoints Blockade Therapy Monitoring from Liquid Biopsy
由: Sai Mummareddy, et al.
出版: (2021-12-01)

PD-1/PD-L1 immune checkpoint inhibitors in glioblastoma: clinical studies, challenges and potential
由: Tianrui Yang, et al.
出版: (2021-02-01)

PD-L1 expression on malignant cells is no prerequisite for checkpoint therapy
由: Jan Willem Kleinovink, et al.
出版: (2017-04-01)

Epigenetic modifications of the immune-checkpoint genes CTLA4 and PDCD1 in non-small cell lung cancer results in increased expression
由: Sebastian Marwitz, et al.
出版: (2017-05-01)

Immune Checkpoint Inhibitors in Cancer Therapy
由: Yavar Shiravand, et al.
出版: (2022-04-01)

Research Progress on Cardiotoxicity of PD-1/PD-L1 Immune Checkpoint Inhibitors
由: YU Lin, et al.
出版: (2021-08-01)

The Role of Immune Checkpoint Inhibitors in Cancer Therapy
由: Ahmed M. Basudan
出版: (2022-12-01)

The role of immune checkpoint inhibitors in prostate cancer
由: Gabriel Surdacki, et al.
出版: (2019-03-01)

Editorial: The Roles of Checkpoint Inhibitors in Inflammatory Diseases
由: Andreas von Knethen, et al.
出版: (2021-10-01)

Activity and Safety of Immune Checkpoint Inhibitors in Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis
由: Alberto Bongiovanni, et al.
出版: (2021-05-01)

Predictive Biomarkers of Immune Checkpoint Inhibitors-Related Toxicities
由: Ya Xu, et al.
出版: (2020-10-01)

Structural Characterization of a Macrocyclic Peptide Modulator of the PD-1/PD-L1 Immune Checkpoint Axis
由: Edyta Zyla, et al.
出版: (2021-08-01)

The Neonatal Innate Immune Response to Sepsis: Checkpoint Proteins as Novel Mediators of This Response and as Possible Therapeutic/Diagnostic Levers
由: Emily Hensler, et al.
出版: (2022-07-01)

Key questions about the checkpoint blockade-are microRNAs an answer?
由: Mihnea Dragomir, et al.
出版: (2018-06-01)

Vascular Targeting to Increase the Efficiency of Immune Checkpoint Blockade in Cancer
由: Maria Georganaki, et al.
出版: (2018-12-01)

Enhancement of anti-tumor efficacy of immune checkpoint blockade by alpha-TEA
由: William L. Redmond, et al.
出版: (2023-02-01)

The epigenetic immunomodulator, HBI-8000, enhances the response and reverses resistance to checkpoint inhibitors
由: Reid P. Bissonnette, et al.
出版: (2021-08-01)

Advances in immune checkpoint inhibitors for hepatocellular carcinoma
由: Ji Won Han, et al.
出版: (2021-09-01)

Immune Checkpoint Inhibitors: Ctla-4 and Pd-1/Pd-l1 in Immunotherapy
由: Kübra KAHVECİ, et al.
出版: (2019-12-01)

Radiation, Immune Checkpoint Blockade and the Abscopal Effect: A Critical Review on Timing, Dose and Fractionation
由: Zachary S. Buchwald, et al.
出版: (2018-12-01)

Safety and efficacy of PD-1/PD-L1 immune checkpoint inhibitors in patients with pre-treated advanced stage malignant mesothelioma: a systematic review and meta-analysis
由: Amjad Zafar, et al.
出版: (2024-11-01)

The impact of antibiotic use on clinical features and survival outcomes of cancer patients treated with immune checkpoint inhibitors
由: Jiaxin Zhou, et al.
出版: (2022-07-01)

Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
由: Adel Naimi, et al.
出版: (2022-04-01)

Editorial: Biomarkers of Immune-Checkpoint-Inhibitor Immunotherapies in Hepatocellular Carcinomas
由: Zhanjun Guo, et al.
出版: (2022-03-01)

Profiling targetable immune checkpoints in osteosarcoma
由: Troy A McEachron, et al.
出版: (2018-12-01)

The Use of Phytochemicals to Improve the Efficacy of Immune Checkpoint Inhibitors: Opportunities and Challenges
由: Deniz Can Guven, et al.
出版: (2022-10-01)

Commentary: Chronic PD-1 Checkpoint Blockade Does Not Affect Cognition or Promote Tau Clearance in a Tauopathy Mouse Model
由: Kuti Baruch, et al.
出版: (2020-05-01)

NSCLC: from tumorigenesis, immune checkpoint misuse to current and future targeted therapy
由: Leona Raskova Kafkova, et al.
出版: (2024-02-01)

Efficacy and safety of immune checkpoint inhibitors in non-small cell lung cancer
由: Shuai Wang, et al.
出版: (2018-08-01)

PD/1-PD-Ls Checkpoint: Insight on the Potential Role of NK Cells
由: Silvia Pesce, et al.
出版: (2019-06-01)

In Search of Better Peptide-(Derived from PD-L2)-Based Immune Checkpoint Inhibitors
由: Boris Klebansky, et al.
出版: (2024-05-01)